⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL793679 | 0.77 | — | — | |
| SCHEMBL18190279 | 0.73 | — | — | |
| SCHEMBL7749359 | 0.72 | — | — | |
| SCHEMBL3482621 | 0.72 | — | — | |
| SCHEMBL1064584 | 0.72 | — | — | |
| SCHEMBL10455547 | 0.71 | — | — | |
| SCHEMBL263285 | 0.67 | TSHR (0.33) | — | |
| SCHEMBL5014823 | 0.65 | — | — | |
| SCHEMBL15870623 | 0.65 | — | — | |
| SCHEMBL5758677 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 295 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3172187-A1 | SUBSTITUTED CYANO CYCLOALKYL PENTA-2,4-DIENES, CYANO CYCLOALKYL PENT-2-EN-4-YNES, CYANO HETEROCYCLYL PENTA-2,4-DIENES AND CYANO HETEROCYCLYL PENT-2-EN-4-YNES AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS | Bayer CropScience Aktiengesellschaft (DE) | 2017-05-31 | — | — | EP | claimed |
| US-9412944-B2 | Organic molecular memory | KABUSHIKI KAISHA TOSHIBA (JP) | 2016-08-09 | — | — | US | claimed |
| US-20160087203-A1 | ORGANIC MOLECULAR MEMORY | KABUSHIKI KAISHA TOSHIBA (JP) | 2016-03-24 | — | — | US | claimed |
| WO-2016012362-A1 | SUBSTITUTED CYANO CYCLOALKYL PENTA-2,4-DIENES, CYANO CYCLOALKYL PENT-2-EN-4-YNES, CYANO HETEROCYCLYL PENTA-2,4-DIENES AND CYANO HETEROCYCLYL PENT-2-EN-4-YNES AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-01-28 | — | — | WO | claimed |
| US-6916942-B2 | Process for the preparation of C-4 carbonate taxanes | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-07-12 | — | — | US | claimed |
| US-20040225009-A1 | Process for the preparation of C-4 carbonate taxanes | BRISTOL-MYERS SQUIBB COMPANY | 2004-11-11 | — | — | US | claimed |
| US-20240131176-A1 | SYNERGISTIC EFFECTS BETWEEN AURISTATIN-BASED ANTIBODY DRUG CONJUGATES AND INHIBITORS OF THE PI3K-AKT MTOR PATHWAY | SEAGEN INC (US) | 2024-04-25 | — | — | US | disclosed |
| US-20240043556-A1 | ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 158P1D7 PROTEINS | AGENSYS, INC. (US) | 2024-02-08 | — | — | US | disclosed |
| US-11879019-B2 | Dual-enzyme responsive peptides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-01-23 | — | — | US | disclosed |
| US-20230346968-A1 | ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS | AGENSYS, INC. (US) | 2023-11-02 | — | — | US | disclosed |
| US-20230321052-A1 | ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF | XOMA (US) LLC | 2023-10-12 | — | — | US | disclosed |
| US-20230270871-A1 | MARKERS FOR USE IN METHODS FOR TREATING CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) | AGENSYS, INC. (US) | 2023-08-31 | — | — | US | disclosed |
| EP-4168039-A1 | MARKERS FOR USE IN METHODS FOR TREATING CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) | Agensys, Inc. (US) | 2023-04-26 | — | — | EP | disclosed |
| US-5773461-A | ANTITUMOR AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-06-30 | — | — | US | disclosed |
| US-5773464-A | ANTITUMOR AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-06-30 | — | — | US | disclosed |
| US-5739359-A | DEACETYLATION; CYCLIZING TO ACETONIDE DERIVATIVE; ESTERIFICATION; DEPROTECTING | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 1998-04-14 | — | — | US | disclosed |
| WO-1998014187-A1 | C-10 EPOXY TAXANES | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-04-09 | — | — | WO | disclosed |
| WO-1997046232-A1 | 7-DEOXY-6-SUBSTITUTED PACLITAXELS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-12-11 | — | — | WO | disclosed |
| US-5635531-A | ANTITUMOR AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-06-03 | — | — | US | disclosed |
| EP-0747385-A1 | Prodrugs of paclitaxel derivatives | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-11 | — | — | EP | disclosed |